Becton Dickinson & Co. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Becton Dickinson & Co. (BDX) shares fell 2.07% to $150.65 on Tuesday, underperforming the broader market as the S&P 500 and Dow Jones rose. This decline ended a three-day winning streak, with BDX trading 19.59% below its 52-week high. While competitors like Danaher, Medtronic, and DexCom also saw declines, BDX's performance was mixed relative to peers. Trading volume remained below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Becton Dickinson & Co. (BDX) slid 2.07% to $150.65 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,543.59 and the Dow Jones Industrial Average rising 0.02% to 52,508.27.
The stock's fall snapped a three-day winning streak.
Becton Dickinson & Co. closed 19.59% below its 52-week high of $187.35, which the company achieved on February 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Danaher Corp. (DHR) fell 0.55% to $199.05, Medtronic PLC (MDT) fell 5.11% to $79.30, and DexCom Inc. (DXCM) fell 2.92% to $74.12.
Trading volume (1.9 M) remained 1.1 million below its 50-day average volume of 2.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-14-26 1652ET